Serum Prolidase Activity and Oxidative Stress in Diabetic Nephropathy and End Stage Renal Disease: A Correlative Study with Glucose and Creatinine

Biochemistry Research International

Volumn 2014, Issue , 2014, Pages

  Verma, Akhilesh Kumar ^a   Chandra, Subhash ^a   Singh, Rana Gopal ^a   Singh, Tej Bali ^a   Srivastava, Shalabh ^b   Srivastava, Ragini ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b JAIPUR DENTAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TOSCANA VIRUS;

EID: 84919333113     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2014/291458     Document Type: Article

References (26)

1. R. E. Gilbert and M. E. Cooper, "The tubulointerstitium in progressive diabetic kidney disease: A more than an aftermath of glomerular injury? Kidney International, vol. 56, no. 5, pp. 1627-1637, 1999.
2. C. E. Mogensen, C. K. Christensen, and E. Vittinghus, "The stages in diabetic renal disease: A with emphasis on the stage of incipient diabetic nephropathy, " Diabetes, vol. 32, no. 2, pp. 64-78, 1983.
3. J. Pickup and G. Williams, Text Book of Diabetes, Blackwell Science, 2nd edition, 1997.
4. C. R. Kahn, G.C.Weir, G. L. King, A.M. Jacobson, A. C.Moses, and R. J. Smith, Joslins Diabetes Mellitus, Indian ed., Lippincott Williams &Wilkins, Philadelphia, Pa, USA, 14th edition, 2005.
5. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, "Diabetes, oxidative stress, and antioxidants: A review, " Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24-38, 2003.
6. E.Uzar, Y.Tamam, O. Evliyaoglu et al., "Serumprolidase activity and oxidative status in patients with diabetic neuropathy, " Neurological Sciences, vol. 33, no. 4, pp. 875-880, 2012.
7. G. Zanaboni, K. M. Dyne, A. Rossi, V. Monafo, and G. Cetta, "Prolidase deficiency: A biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients., " Haematologica, vol. 79, no. 1, pp. 13-18, 1994.
8. I. Myara, A. Myara, M. Mangeot, M. Fabre, C. Charpentier, and A. Lemonnier, "Plasma prolidase activity: A possible index of collagen catabolism in chronic liver disease, " Clinical Chemistry, vol. 30, no. 2, pp. 211-215, 1984.
9. A. B. Erbagci, M. Araz, A. Erbaʇci, M. Tarakçioʇlu, and E. S. Namiduru, "Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus, " Clinical Biochemistry, vol. 35, no. 4, pp. 263-268, 2002.
10. M. Savas, E. Yeni, H. Celik et al., "The association of serumprolidase activity and erectile dysfunction, " Journal of and rology, vol. 31, no. 2, pp. 146-154, 2010.
11. S. Kumari, A. K. Verma, S. Rungta, R. Mitra, R. Srivastava, and N. Kumar, "Serum prolidase activity, oxidant and anti-oxidant status in non-ulcer dyspepsia and healthy volunteers, " ISRN Biochemistry, vol. 2013, Article ID 182601, 6 pages, 2013.
12. M. Bergmann and J. S. Fruton, "On proteolytic enzymes, XII, regarding the specificity of aminopeptidase and carboxypeptidase, a new type of enzyme in the intestinal tract, " The Journal of Biological Chemistry, vol. 117, pp. 189-202, 1937.
13. A. Surazynski, W. Miltyk, J. Palka, and J. M. Phang, "Prolidasedependent regulation of collagen biosynthesis, " Amino Acids, vol. 35, no. 4, pp. 731-738, 2008.
14. J. A. Palka and J. M. Phang, "Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors, " Journal of Cellular Biochemistry, vol. 67, pp. 166-175, 1997.
15. O. Erel, "A novel automated method to measure total antioxidant response against potent free radical reactions, " Clinical Biochemistry, vol. 37, no. 2, pp. 112-119, 2004.
16. O. Erel, "A new automated colorimetric method for measuring total oxidant status, " Clinical Biochemistry, vol. 38, no. 12, pp. 1103-1111, 2005.
17. A. S. Levey, L. A. Stevens, C. H. Schmid et al., "Anewequation to estimate glomerular filtration rate, " Annals of InternalMedicine, vol. 150, no. 9, pp. 604-612, 2009.
18. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, "Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy, " Diabetes, vol. 55, no. 1, pp. 225-233, 2006.
19. R. P.Robertson, J.Harmon, P. O. T. Tran, and V. Poitout, "β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes, " Diabetes, vol. 53, supplement 1, pp. S119-S124, 2004.
20. S. Shah, M. Iqbal, J. Karam, M. Salifu, and S. I. McFarlane, "Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: A pathophysiological insights, " Antioxidants and Redox Signaling, vol. 9, no. 7, pp. 911-929, 2007.
21. R. P. Robertson and J. S. Harmon, "Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet β cell, " Free Radical Biology and Medicine, vol. 41, no. 2, pp. 177-184, 2006.
22. R. Srivastava, R. Lohokare, and R. Prasad, "Oxidative stress in children with bacterial meningitis, " Journal of Tropical Pediatrics, vol. 59, no. 4, pp. 305-308, 2013.
23. R. Srivastava, A. Kashyap, M. Kumar, G. Nath, and A. K. Jain, "Mucosal IgA & IL-1β in helicobacter pylori infection, " Indian Journal of Clinical Biochemistry, vol. 28, no. 1, pp. 19-23, 2013.
24. L.Monnier, E.Mas, C.Ginet et al., "Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes, " Journal of the American Medical Association, vol. 295, no. 14, pp. 1681-1687, 2006.
25. H. Terawaki, K. Yoshimura, T.Hasegawa et al., "Oxidative stress is enhanced in correlation with renal dysfunction: A examination with the redox state of albumin, " Kidney international, vol. 66, no. 5, pp. 1988-1993, 2004.
26. K.-C. Huang, C.-C. Yang, K.-T. Lee, and C.-T. Chien, "Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water, " Kidney International, vol. 64, no. 2, pp. 704-714, 2003.